Clinical Nurse Manager, Outpatient Surgery Center
Position Summary
This position is responsible for planning, organizing, directing, and coordinating the administrative operations of a
new $17 million dollar center opening in the summer of 2011.
Primary Responsibilities












Directs the day-to-day activities and operations of the surgery center which includes (4) ORs and (4)
procedure rooms and approximately 20 FTEs.
Serves as a liaison between the Center, the community, and the other local healthcare providers.
Fosters and maintains a collegial relationship with physicians.
Develops methods and systems to collect and monitor data to achieve optimum performance and ensure
the highest standards of care are delivered.
Analyzes all surgery center financial reports (Fees, A/R, A/P, and Insurance Reimbursement)
Prepares and maintains operating, capital, and cash budgets for the facility.
Monitors facility operating statistics and referral patterns to isolate trends.
Monitors budgeted procedure volumes.
Establishes and implements a protocol for ordering supplies, equipment, narcotics, etc. Monitors supply
usage and costs.
Monitors case cost analysis.
Plans for future improvement in procedures and organization of the surgery center.
Recommends and plans new programs to be developed within the surgery center
Ideal Experience





BSN required, Masters or MBA desired.
5 years in a leadership capacity.
Experienced in outpatient surgery center development and operations. CASA certification desired.
Strong knowledge of state licensure and TJC regulations related to an ambulatory surgery center.
Computer literate and skilled in Excel and PowerPoint.
Personal Characteristics






Builds and maintains collaborative relationships across all functions and levels within the organization.
Exhibits flexibility while influencing others to improve processes and implement changes.
Anticipates needs, responds quickly, provides guidance and support, monitors and follows up as
required.
Demonstrates outstanding communication skills. Produces concise, incisive, logical written documents.
Approaches change by accomplishing milestones and works with and through others to drive change.
Expresses commitment to City of Hope’s mission, personally identifies with its vision and takes pride in
shared success.
Key words: Nurse, Nurse Manager, Outpatient Surgery, Outpatient Surgical, RN, NP, Nurse Practitioner, Surgical
Oncology, Ambulatory.
For immediate consideration, please visit
https://recruiting.cityofhope.org/psc/RECRUITING/EMPLOYEE/HRMS/c/HRS_HRAM.HRS_CE.GBL to apply for the
Clinical Nurse Manager, Outpatient Surgery Center position.
City of Hope provides an environment of diversity, discovery and unlimited possibilities and is an Equal
Opportunity Employer.
City of Hope’s Mission
City of Hope, an innovative biomedical research, treatment and educational institution, is dedicated to the
prevention and cure of cancer and other life-threatening diseases, guided by a compassionate, patient-centered
philosophy and supported by a national foundation of humanitarian philanthropy.
Founded in 1913 and headquartered in Duarte, California, City of Hope is a remarkable non-profit institution,
where compassion and advanced care go hand-in-hand with excellence in clinical and scientific research. City
of Hope is a National Cancer Institute designated Comprehensive Cancer Center (one of only 40 in the United
States) and a founding member of the National Comprehensive Cancer Network, an alliance of the nation’s 20
leading cancer centers that develops and institutes standards of care for cancer treatment.
City of Hope supports the medical and scientific missions of its two distinct but fully integrated subsidiaries: City
of Hope National Medical Center and the Beckman Research Institute. The scenic campus encompasses 115
acres and includes more than 300 physicians and scientists and over 3800 employees.
City of Hope National Medical Center
The Medical Center comprises a Comprehensive Cancer Center with a strong commitment to clinical and
translational research, and humanitarian and compassionate care. City of Hope has a distinguished record of
achievements in clinical and basic research. Peer-reviewed funding has tripled since the mid-90s. For FY 2009,
City of Hope is projected to receive $56 million of extramural funding for sponsored research. In addition to
sponsored research, City of Hope spends over $150 million in institutional funds for basic, translational and
clinical research. It is also home to the Islet Cell Resources Center of Southern California, and the National
Gene Vector Laboratory, both established by NIH grant awards in 2001. City of Hope has been named one of
"America's Best Hospitals" in two specialties by U.S. News & World Report. The institution is one of only five
centers in California, and one of only two in the Los Angeles area, to appear on the list of best cancer centers;
and is one of only six hospitals in California ranked among the best in urology.
City of Hope is the largest provider of bone marrow transplantation services in California, and one of the largest
and most successful programs in the world. The bone marrow transplantation program has grown and
expanded to include the Bone Marrow Transplantation Program in Phoenix, Arizona. The Medical Center is also
the largest provider of Robotic Prostatectomies in the United States.
Beckman Research Institute
Beckman is dedicated to promoting innovative and creative laboratory research as well as educating future
scientists in the biological sciences. The Research Institute provides an environment of academic freedom in
which its investigators can pursue scientific knowledge and discoveries for the greater good of humankind.
Basic research of the highest caliber is directed toward an improved understanding of the essential molecules
and fundamental processes of life, including those processes important to the causes, prevention and cures of
human disease.
City of Hope established its research institute in the 1950s. In 1983, it became the first of five Beckman
Research Institutes established through generous support from the Arnold and Mabel Beckman Foundation.
Divisions and departments include Molecular Biology, Molecular Medicine, Biology, Immunology, Neuroscience,
Virology, Radiation Biology, Surgical Research, Hematological Research, Gene Expression and Drug Discovery,
and Cancer Immunotherapy. The research faculty at the Institute has grown to over 80 Ph.D.s and M.D.s in the
professor series working on a variety of basic and clinical research projects of relevance to cancer.
Page 2
The Graduate School of Biological Sciences was approved by the State of California in 1994 and offers a Ph.D.
degree in diverse fields of biological sciences. Accreditation was awarded in February 2001 by the Western
Association of Schools and Colleges (WASC) and average 60-65 doctoral students. In addition, the Institute is
home to an active undergraduate summer research program that provides a stimulating laboratory research
experience for 30-50 students annually, many of whom are from minority communities.
The impact of Beckman is evidenced by its scientific accomplishments, including the first laboratory synthesis of
human insulin and the development of recombinant human growth hormone. City of Hope researchers also first
demonstrated that antibodies could be made using recombinant (genetically engineered) DNA technology which
led to one of the dominant patents in the field of recombinant antibodies. Genentech used this technology to
create the cancer-fighting drugs Herceptin®, Rituxan® and Avastin®, which represent a major source of
royalty income for research support. Looking forward, City of Hope is poised to extend its preeminence in stem
cell transplantation and research as well as experimental therapeutics for cancer and other diseases.
Throughout its history, Beckman has promoted translational research, emphasizing the importance of moving
discoveries from the laboratory bench to the patient bedside. The opening of the Center for Biomedicine and
Genetics (CBG) has greatly enhanced this effort. CBG is the largest pilot “Good Manufacturing Process” (GMP)
facility of its type (20,650 square feet) in an academic setting in the U.S. The Center was developed to produce
clinical-grade biologicals for Phase I and II clinical trials. The CBG is dedicated to facilitating the development
of innovative biologicals discovered by City of Hope investigators, colleagues and partners, and to establishing
working relationships with regional biopharmaceutical and academic organizations. Further development and
commercialization of successful products will be licensed to or co-developed with commercial organizations.
City of Hope Development Group
The City of Hope Development Group is the fundraising arm of the organization and is dedicated to providing
the financial resources to support City of Hope’s innovative research and compassionate care. From its
inception, City of Hope has had a legacy of philanthropy that has grown into a vast worldwide network of over
290,000 volunteers and donors who support its work. The combined efforts of the development group and the
extensive network of support groups have resulted in a steady increase in total contributions. In FY 2009
restricted and unrestricted contributions were $106 million.
City of Hope has been recognized by Forbes magazine as one of the nation’s largest and most efficient charities,
with 85% of donations expended on programs in biomedical research, patient care, and public information and
education.
For many people, City of Hope is where hope begins. To learn more about City of Hope, please visit
www.cityofhope.org
Page 3